Tue, 20 Oct 2026
04:57:31 pm
Rudransh Sangwan
Published at: October 15, 2026, 7:37 AM
Synopsis
Canara Bank shares decline after Q2 FY27 results. Explore the latest share price, brokerage target prices, analyst ratings and outlook for the stock.

Canara Bank shares fell as much as 6.5% to ₹117 on October 15, 2026, despite an 8% year-on-year rise in Q2 FY27 standalone net profit to ₹5,175 crore.
Net interest income (NII) increased 20% to ₹11,005 crore from ₹9,141 crore a year earlier. Brokerages remain divided on the stock.
| Metric | Q2 FY27 |
|---|---|
| Net profit | ₹5,175 crore |
| Profit growth | Over 8% |
| Net interest income | ₹11,005 crore |
| NII growth | Over 20% |
| Intraday share price fall | 6.5% |
| Intraday low | ₹117 |
| Brokerage | Rating | Target Price |
|---|---|---|
| Morgan Stanley | Underweight | ₹109 |
| Motilal Oswal | Buy | ₹160 |
| JM Financial | Buy | ₹150 |
Morgan Stanley expects limited scope for valuation re-rating despite stronger-than-expected quarterly profit. It raised its FY27 and FY28 earnings estimates but remains cautious about the stock's valuation.
Motilal Oswal maintained its Buy rating, citing improved margins, lower provisions and better asset quality. It expects net interest margins of 2.5% to 2.6% in FY27 and loan growth of 11% to 12%.
JM Financial upgraded the stock to Buy, citing improving fundamentals, steady margins and attractive valuations. It also highlighted a 14% rise in book value over the past year.
Key factors include deposit growth, net interest margins, asset quality and the potential impact of expected credit loss provisions. Canara Bank may need additional provisions of ₹12,000 crore to ₹15,000 crore, potentially affecting its capital adequacy ratio by 1 to 1.2 percentage points.
Canara Bank reported stronger Q2 FY27 earnings, but its shares declined sharply. While Motilal Oswal and JM Financial remain positive, Morgan Stanley is cautious about valuation. Investors should assess the risks and their financial goals before making investment decisions.

Financial journalist specializing in market analysis, stock research, and investment trends. Dedicated to providing accurate, timely insights for informed decision-making.
Credentials: Experienced financial journalist with expertise in equity markets and economic analysis
The information provided in this article is for educational and informational purposes only and should not be construed as financial, investment, or legal advice. welomoney does not provide personalized investment recommendations.
For detailed terms and conditions, please read our Disclaimer and Terms of Service.

L&T has begun preliminary work on the New Tashkent International Airport project after receiving a limited notice to proceed.

DLF share price has 41% upside, according to HSBC’s target. Compare Jefferies, CLSA and other broker views on sales, cash flow and valuations.

Divi's Laboratories shares rose 1.01% to Rs 9,242.50 after a positive EU opinion on Eli Lilly's weight loss drug Foundayo. See the growth outlook.

Awfis revenue target exceeds Rs 1,800 crore for FY27, with flexible workspace demand supporting growth. Expansion and execution remain key to watch.

L&T has won a contract worth over Rs 15,000 crore. The client, project scope and execution timeline remain undisclosed, leaving its revenue impact...